Fidelity Investments’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$405M Sell
8,403,449
-308,802
-4% -$21.1M 0.02% 586
2025
Q4
$606M Buy
8,712,251
+3,461,883
+66% +$141M 0.03% 441
2025
Q3
$147M Buy
5,250,368
+335,403
+7% +$6.68M 0.01% 996
2025
Q2
$102M Sell
4,914,965
-968,742
-16% -$21.3M 0.01% 1110
2025
Q1
$102M Sell
5,883,707
-195,039
-3% -$4.78M 0.01% 1090
2024
Q4
$165M Sell
6,078,746
-49,698
-0.8% -$1.76M 0.01% 898
2024
Q3
$269M Buy
6,128,444
+383,635
+7% +$14.8M 0.02% 711
2024
Q2
$226M Buy
5,744,809
+2,796,045
+95% +$115M 0.01% 744
2024
Q1
$126M Sell
2,948,764
-1,085,820
-27% -$45.8M 0.01% 966
2023
Q4
$164M Buy
4,034,584
+2,444,249
+154% +$140M 0.01% 826
2023
Q3
$80.2M Buy
1,590,335
+352,600
+28% +$11.4M 0.01% 1064
2023
Q2
$51.5M Sell
1,237,735
-11,691
-0.9% -$328K ﹤0.01% 1265
2023
Q1
$29.7M Buy
+1,249,426
New +$29.4M ﹤0.01% 1449

Other funds holding GPCR